Skip to main content

Table 3 Baseline characteristics

From: Update of the Preventive Antibiotics in Stroke Study (PASS): statistical analysis plan

Baseline characteristics

Ceftriaxone + standard care

Standard care

Age - years

  

Male sex - % n/N

  

Medical history - % n/N

  

- Atrial fibrillation/flutter

  

- Stroke

  

- Hypercholesterolemia

  

- Hypertension

  

- Myocardial infarction

  

- Cardiac valve insufficiency/stenosis/replacement

  

- Peripheral vascular disease

  

- Obstructive pulmonary disease

  

- Immunocompromised

  

Current smoker - % n/N

  

Medication prior to stroke - % n/N

  

- Anticoagulants

  

- Antiplatelet

  

- Statin

  

- ACE inhibitor

  

- Bèta-blocker

  

- Proton pump inhibitor

  

Disability prior to stroke - mRS *

  

Stroke severity - NIHSS **

  

Swallowing screening performed - % n/N

  

Dysphagic patients - % n/N

  

Acute treatment - % n/N

  

- IV thrombolysis

  

- Coagulant therapy

  

Diagnosis at discharge - % n/N

  

- Infarction

  

- Hemorrhage

  

- Transient ischemic attack (TIA)

  

- Other

  
  1. *mRS, denotes modified Rankin Scale.
  2. **NIHSS denotes National Institutes of Health Stroke Scale.